McLaughlin J - Search Results

1

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N. Kelliher M, et al. Among authors: mclaughlin j. Mol Cell Biol. 1991 Sep;11(9):4710-6. doi: 10.1128/mcb.11.9.4710-4716.1991. Mol Cell Biol. 1991. PMID: 1875948 Free PMC article.

2

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Kelliher MA, McLaughlin J, Witte ON, Rosenberg N. Kelliher MA, et al. Among authors: mclaughlin j. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6649-53. doi: 10.1073/pnas.87.17.6649. Proc Natl Acad Sci U S A. 1990. PMID: 2204061 Free PMC article.

3

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

McLaughlin J, Chianese E, Witte ON. McLaughlin J, et al. Mol Cell Biol. 1989 May;9(5):1866-74. doi: 10.1128/mcb.9.5.1866-1874.1989. Mol Cell Biol. 1989. PMID: 2747638 Free PMC article.

4

Oncogenic activation of c-ABL by mutation within its last exon.

Goga A, McLaughlin J, Pendergast AM, Parmar K, Muller A, Rosenberg N, Witte ON. Goga A, et al. Among authors: mclaughlin j. Mol Cell Biol. 1993 Aug;13(8):4967-75. doi: 10.1128/mcb.13.8.4967-4975.1993. Mol Cell Biol. 1993. PMID: 8336729 Free PMC article.

5

Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.

Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG. Golub TR, et al. Among authors: mclaughlin j. Mol Cell Biol. 1996 Aug;16(8):4107-16. doi: 10.1128/MCB.16.8.4107. Mol Cell Biol. 1996. PMID: 8754809 Free PMC article.

6

Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors.

Wong S, McLaughlin J, Cheng D, Witte ON. Wong S, et al. Among authors: mclaughlin j. Blood. 2003 May 15;101(10):4088-97. doi: 10.1182/blood-2002-11-3376. Epub 2003 Jan 9. Blood. 2003. PMID: 12521991 Free article.

7

Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia.

Signer RA, Montecino-Rodriguez E, Witte ON, McLaughlin J, Dorshkind K. Signer RA, et al. Among authors: mclaughlin j. Blood. 2007 Sep 15;110(6):1831-9. doi: 10.1182/blood-2007-01-069401. Epub 2007 Jun 6. Blood. 2007. PMID: 17554060 Free PMC article.

8

The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.

Gishizky ML, McLaughlin J, Pendergast AM, Witte ON. Gishizky ML, et al. Among authors: mclaughlin j. Oncogene. 1991 Aug;6(8):1299-306. Oncogene. 1991. PMID: 1886706

9

The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.

Daley GQ, McLaughlin J, Witte ON, Baltimore D. Daley GQ, et al. Among authors: mclaughlin j. Science. 1987 Jul 31;237(4814):532-5. doi: 10.1126/science.2440107. Science. 1987. PMID: 2440107

10

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

McLaughlin J, Chianese E, Witte ON. McLaughlin J, et al. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6558-62. doi: 10.1073/pnas.84.18.6558. Proc Natl Acad Sci U S A. 1987. PMID: 3498165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,844 results

Search Page

Filters